Seoulin Bioscience Co Ltd
KOSDAQ:038070
Seoulin Bioscience Co Ltd
Research & Development
Seoulin Bioscience Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Seoulin Bioscience Co Ltd
KOSDAQ:038070
|
Research & Development
-₩1.2B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-8%
|
|
|
Celltrion Inc
KRX:068270
|
Research & Development
-₩218.9B
|
CAGR 3-Years
-91%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Research & Development
-₩17.9B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Research & Development
-₩28.4B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-31%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Research & Development
-₩95.6B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Research & Development
-₩22.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Seoulin Bioscience Co Ltd
Glance View
SeouLin Bioscience Co., Ltd. engages in the provision of lifescience total solutions. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2005-10-25. The firm mainly engages in research and development of reagents, such as deoxyribonucleic acid (DNA) chips, which are used for gene therapy, clinical diagnosis, organs transplantation and biopsy; stem cells, which are used for treatment of incurable diseases, Alzheimer disease and others, and next-generation biotechnology drugs. The firm supplies its products under the brand name MyLab. The company also imports bio research equipment from Thermo Fisher, Affymetrix, Sarstedt and others, and markets in the domestic market. In addition, the Company engages in the real estate rental business.
See Also
What is Seoulin Bioscience Co Ltd's Research & Development?
Research & Development
-1.2B
KRW
Based on the financial report for Sep 30, 2025, Seoulin Bioscience Co Ltd's Research & Development amounts to -1.2B KRW.
What is Seoulin Bioscience Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-8%
Over the last year, the Research & Development growth was -30%. The average annual Research & Development growth rates for Seoulin Bioscience Co Ltd have been -18% over the past three years , -3% over the past five years , and -8% over the past ten years .
